4 Animals AlsterScience GmbH
↗Hamburg, Germany
4 Animals AlsterScience GmbH is a German biotechnology company focused on developing innovative, natural immunotherapies for veterinary medicine. The company aims to strengthen the immune systems of pets and livestock using immune modulators such as interferons and interleukins to treat infections, tumors, and immune function disorders, thereby reducing the reliance on antibiotics.
The company leverages research originally intended for human drug development, optimizing these active substances for veterinary applications. Their product strategy includes developing immune enhancers (adjuvants) to improve vaccine efficacy and creating well-tolerated formulations that can be administered by veterinarians or animal owners.
CLASSIFICATION
SIZE & FINANCIALS
Employees:1-50
Founded:2014
Ownership:private
Status:operating
FUNDING
Stage:Seed
Investors:Innovationsstarter Fonds Hamburg, High-Tech Gründerfonds (HTGF)
PIPELINE
Stage:Preclinical
Lead Drug Stage:Preclinical
Modalities:Biologics, Immunomodulators, Cell therapy
Active Trials:0
Trial Phases:-
FDA Approvals:0
EMA Approvals:0
COMPETITION
Position:Niche Player
LEADERSHIP
Key Executives:
Edith Huland - Chief Scientific Officer / Co-Managing Director
Conny Cloppenburg - Chief Financial Officer / Co-Managing Director
Scientific Founders:Edith Huland
LINKS
Website:alsterscience.com
⚠
Is this information incorrect? This profile was AI-generated from publicly available sources and may contain errors. If you are a representative of 4 Animals AlsterScience GmbH and believe any information on this page is inaccurate, we will promptly correct or remove it.REPORT AN ERROR
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with 4 Animals AlsterScience GmbH. The information on this page was compiled using AI from publicly available sources and may be incomplete, outdated, or contain errors. We are committed to correcting inaccuracies promptly upon notice. For official information, please visit the company's website directly.